RUBINSTEIN JULIE bought ADPT
March 10, 2026 · Form 4 insider transaction
RUBINSTEIN JULIE bought 400 shares of Adaptive Biotechnologies Corporation at $12.14 per share, a transaction worth $4.9K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
400
Price
$12.14
Total value
$4.9K
InsiderRUBINSTEIN JULIE
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 10, 2026
Filing dateMarch 10, 2026
Shares owned after662,931
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.